ArticleJournal of clinical pharmacology2022

Off-Label Use of Hydroxychloroquine in COVID-19: Analysis of Reports of Suspected Adverse Reactions From the Italian National Network of Pharmacovigilance.

Elettra Fallani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.